Overview

European Safety Registry in Ulcerative Colitis (P04808)

Status:
Completed
Trial end date:
2016-10-20
Target enrollment:
Participant gender:
Summary
This is a prospective, safety surveillance registry in participants with moderate-to-severe active ulcerative colitis (UC).
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Collaborator:
Centocor, Inc.
Treatments:
Infliximab